Combined-modality therapy for unresectable, stage III non-small-cell lung cancer--caveat emptor or caveat venditor?

J Natl Cancer Inst. 1996 Sep 4;88(17):1175-7. doi: 10.1093/jnci/88.17.1175.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Small Cell / drug therapy
  • Carcinoma, Small Cell / pathology
  • Carcinoma, Small Cell / radiotherapy
  • Carcinoma, Small Cell / therapy*
  • Dose-Response Relationship, Drug
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Lung Neoplasms / radiotherapy
  • Lung Neoplasms / therapy*
  • Neoplasm Staging
  • Radiotherapy Dosage
  • Survival Analysis
  • Treatment Outcome